Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine
- 1 January 1992
- Vol. 10 (10) , 673-676
- https://doi.org/10.1016/0264-410x(92)90088-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinantsVirology, 1990
- Disseminated Adenovirus Infection with Hepatic Necrosis in Patients with Human Immunodeficiency Virus Infection and Other Immunodeficiency StatesClinical Infectious Diseases, 1990
- Acute diarrhea in Baltimore children attending an outpatient clinicThe Pediatric Infectious Disease Journal, 1988
- A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factorCell, 1988
- A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulumCell, 1987
- Disseminated Vaccinia in a Military Recruit with Human Immunodeficiency Virus (HIV) DiseaseNew England Journal of Medicine, 1987
- Safety and Immunogenicity of Live Attenuated Rhesus Monkey Rotavirus VaccineThe Journal of Infectious Diseases, 1986
- Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillanceCell, 1985
- An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigensCell, 1985
- Isolation of deletion and substitution mutants of adenovirus type 5Cell, 1978